
Biomarkers, Genetics, and Anti-Amyloid Therapies for Early Stages of AD
22/8/2025
0:00
26:06
Using biomarker testing and APOE genotyping to determine patient eligibility for amyloid-targeting therapies.
Credit available for this activity expires: 8/19/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002844?ecd=bdc_podcast_libsyn_mscpedu
Altri episodi di "Keeping Current CME"
Non perdere nemmeno un episodio di “Keeping Current CME”. Iscriviti all'app gratuita GetPodcast.